National Heart, Lung, and Blood Institute; Notice of Closed Meeting, 2880-2881 [2022-00901]
Download as PDF
<![CDATA[
jspears on DSK121TN23PROD with NOTICES1
2880
Federal Register / Vol. 87, No. 12 / Wednesday, January 19, 2022 / Notices
Date: March 7, 2022.
Time: 3:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, National Institutes of Health,
6710B Rockledge Drive, Room 2121B,
Bethesda, MD 20892 (Video Assisted
Meeting).
Contact Person: Christiane M. Robbins,
Scientific Review Officer, Scientific Review
Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, National Institute of Health,
6710B Rockledge Drive, Room 2121B,
Bethesda, MD 20892, (301) 451–4989,
crobbins@mail.nih.gov.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Pelvic Floor
Disorders Network (UG1 Clinical Research).
Date: March 17, 2022.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, National Institutes of Health,
6710B Rockledge Drive, Room 2131B,
Bethesda, MD 20892 (Video Assisted
Meeting).
Contact Person: Luis E. Dettin, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, National Institute of Health,
6710B Rockledge Drive, Room 2131B,
Bethesda, MD 20892, (301) 827–8231, luis_
dettin@nih.gov.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Pelvic Floor
Disorders Network (U24 Resource-Related
Research Projects).
Date: March 18, 2022.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, National Institutes of Health,
6710B Rockledge Drive, Room 2131B,
Bethesda, MD 20892 (Video Assisted
Meeting).
Contact Person: Luis E. Dettin, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, National Institutes of Health,
6710B Rockledge Drive, Room 2131B,
Bethesda, MD 20892, (301) 827–8231, luis_
dettin@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
VerDate Sep<11>2014
16:58 Jan 18, 2022
Jkt 256001
Dated: January 13, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2022–00963 Filed 1–18–22; 8:45 am]
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel; Knock Out Mouse Phenotyping
Program (KOMP2).
Date: March 10, 2022.
Time: 12:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, National Institutes of Health, 6700B
Rockledge Drive, Suite 3100, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Barbara J. Thomas, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Human Genome Research
Institute, National Institutes of Health, 6700B
Rockledge Drive, Suite 3100, Bethesda, MD
20892, 301–402–8837, barbara.thomas@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Dated: January 12, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–00900 Filed 1–18–22; 8:45 am]
Frm 00135
Fmt 4703
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Heart, Lung, and
Blood Initial Review Group; NHLBI
Mentored Patient-Oriented Research Study
Section.
Date: March 3–4, 2022.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6705
Rockledge Drive, Bethesda, MD 20817
(Virtual Meeting).
Contact Person: Stephanie Johnson Webb,
Ph.D., Scientific Review Officer, Office of
Scientific Review/DERA, National Heart,
Lung, and Blood Institute, National Institutes
of Health, 6705 Rockledge Drive, Room 208–
V, Bethesda, MD 20892, (301) 827–7992,
stephanie.webb@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: January 12, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–00899 Filed 1–18–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
BILLING CODE 4140–01–P
PO 00000
National Institutes of Health
Sfmt 4703
E:\FR\FM\19JAN1.SGM
19JAN1
Federal Register / Vol. 87, No. 12 / Wednesday, January 19, 2022 / Notices
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Heart, Lung, and
Blood Initial Review Group; Clinical Trials
Review Study Section.
Date: March 3–4, 2022.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6705
Rockledge Drive, Bethesda, MD 20817
(Virtual Meeting).
Contact Person: Keary A. Cope, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Room 209–A,
Bethesda, MD 20892–7924, (301) 827–7912,
copeka@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: January 12, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–00901 Filed 1–18–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
jspears on DSK121TN23PROD with NOTICES1
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act. To request a
copy of these documents, call the
SAMHSA Reports Clearance Officer on
(240) 276–0361.
Project: Revision of Mental Health
Client/Participant Outcome Measures
and Infrastructure, Prevention, and
Mental Health Promotion Indicators
(OMB No. 0930–0285)
SAMHSA is requesting approval from
the Office of Management and Budget
(OMB) for revisions to the previously
VerDate Sep<11>2014
16:58 Jan 18, 2022
Jkt 256001
approved instruments and data
collection activities for the Government
Performance and Results Act (GPRA)
Center Mental Health Services (OMB No
0930–0285) that expires on February 28,
2022.
To be fully accountable for the
spending of federal funds, SAMHSA
requires all programs to collect and
report data to ensure that program goals
and objectives are met. Data is collected
and used to monitor and improve
performance of each program and
ensure appropriate and thoughtful
spending of federal funds.
SAMHSA requests the following
revisions to the NOMS Mental Health
Client/Participant Outcome measures:
(1) Merge the CMHS NOMS Child
Client-level Measures for Discretionary
Programs data collection instrument
with the current CMHS NOMS Adult
Client-level Measures for Discretionary
Programs data collection instrument; (2)
delete questions for data not being
utilized for program monitoring and
quality improvement; (3) reduce grantee
burden by shifting questions for a fivepoint psychometric response scale to
‘‘Yes’’, ‘‘No’’, and ‘‘No response/
Refused’’ responses; (4) modify IDC–10
diagnoses to expand the F 40–48, F60–
63, and F90–99 codes to allow for more
specificity. Also, add ICD–10 ‘‘Z’’ codes
to allow for a focus on social
determinants of health that may affect
the diagnosis, course, prognosis, or
treatment of a client/consumer mental
disorder; (6) shift reporting NOMS data
to baseline assessment, 3-month or 6month reassessment, and a final clinical
discharge assessment; (7) reduce the
number of physical health indictors and
reporting frequency from quarterly to
three points in time (baseline, 3- or 6month reassessment, clinical discharge).
SAMHSA also requests the following
revisions to the Infrastructure,
Prevention, and Mental Health
Promotion indicators:
(1) Delete four indicators not used by any
SAMSHA programs: PD1: The number of
policy changes completed as a result of the
grant; WD4: The number of changes made to
credentialing and licensing policies in order
to incorporate expertise needed to improve
mental health-related practices/activities; F1:
The amount of additional funding obtained
for specific mental health-related practices/
activities that are consistent with the goals of
the grant; and O2: The total number of
contacts made through program outreach
efforts).
(2) Revise two indicators to provide more
clarity A3: The number of communities that
enhance health information-sharing for
provision of services between agencies and
program; and A1: The number of grant
project activities in which fidelity is
monitored as a result of the grant); and
PO 00000
Frm 00136
Fmt 4703
Sfmt 4703
2881
(3) Add eleven indicators to reflect
program developments during the past three
years: R2: The number of individuals referred
to trauma-informed care services as a result
of the grant; R3: The number of individuals
referred to crisis or other mental health
services for suicidality; S2: The number of
individuals screened for trauma-related
experiences as a result of the grant; S3: The
number of individuals screened for suicidal
ideation as a result of the grant; T5: The
number of activities modified, adapted, or
changed to reflect trauma-informed practices
for the population(s) being served by the
grant; T6: The number of activities modified,
adapted, or changed to reflect culturally
appropriate services for the population(s)
being served by the grant; T7: As a result of
the grant, reduce the percentage of
individuals who died by suicide; and T8: As
a result of the grant, reduce the number of
individuals who attempted suicide).
These changes will lessen grantee
burden with data collection and
improve capacity to report qualitative
performance and quantitative outcomes
for all discretionary grant programs,
including: Demographic characteristics
of clients’ served; clinical characteristics
of clients’ served before, during, and
after receipt of services; numbers of
clients served; and characteristics of
services and activities provided to
clients’.
Currently, the information collected
from this instrument is entered and
stored on SAMHSA’s Performance
Accountability and Reporting System
(SPARS), a real-time, performance
management system that captures
information on mental health and
substance abuse treatment services
delivered in the United States.
Continued approval of this information
collection will allow SAMHSA to
continue to meet Government
Performance and Results Modernization
Act of 2010 (GPRMA) reporting
requirements that quantify the effects
and accomplishments of its
discretionary grant programs, which are
consistent with OMB guidance.
SAMHSA and its Centers will use the
data collected for annual reporting
required by required by GPRMA, to
describe and understand changes in
outcomes from baseline to follow-up to
discharge. SAMHSA and its Centers will
use the data for annual reporting
comparing baseline with discharge and
follow-up data. SAMHSA’s report for
each fiscal year will include actual
results of performance monitoring for
the three preceding fiscal years.
Information collected through this
request will allow SAMHSA to report
on the results of these performance
outcomes as well as be consistent with
SAMHSA-specific performance
domains, and to assess the
E:\FR\FM\19JAN1.SGM
19JAN1
]]>Agencies
[Federal Register Volume 87, Number 12 (Wednesday, January 19, 2022)]
[Notices]
[Pages 2880-2881]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-00901]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
[[Page 2881]]
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Heart, Lung, and Blood Initial Review Group;
Clinical Trials Review Study Section.
Date: March 3-4, 2022.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6705 Rockledge Drive,
Bethesda, MD 20817 (Virtual Meeting).
Contact Person: Keary A. Cope, Ph.D., Scientific Review Officer,
Office of Scientific Review/DERA, National Heart, Lung, and Blood
Institute, National Institutes of Health, 6705 Rockledge Drive, Room
209-A, Bethesda, MD 20892-7924, (301) 827-7912, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: January 12, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-00901 Filed 1-18-22; 8:45 am]
BILLING CODE 4140-01-P
